Matthew Price, MD
Interventional Cardiology · la Jolla, CANPI 1659343945
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (47.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Boston Scientific at 57.9% of the total. 2025 is the largest year on record at $1,323,916, 7.8 times the $170,506 reported in 2019. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,607 payments — averaging $1436.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1.3M
- Abbott$335K
- W. L. Gore & Associates, Inc.$176K
- Philips North America LLC$146K
- Shockwave Medical, Inc$140K
- Medtronic$78K
- plus $96K from 38 others
Across 524 payments — averaging $6597.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$2M
- Medtronic$420K
- Boston Scientific$418K
- Shockwave Medical, Inc$407K
- Edwards Lifesciences$92K
- Biosense Webster, Inc.$52K
- plus $75K from 2 others
What the payments were for
- Consulting fees$671,25229%
- Speaking & faculty fees$373,98716%
- Grants$11,6751%
- Travel & lodging$112,9385%
- Food & beverage$50,8022%
- Education$1360%
- Other$1,087,38547%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,104,481
- (9520) IGT Devices Undivided$142,557
- GORE CARDIOFORM Septal Occluder$97,908
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$88,384
- WATCHMAN Access System$78,809
- MitraClip$70,121
- Product in Development$56,139
- Vascular Lithotripsy$50,880
- TRICLIP$50,527
- Watchman$49,125
- AMPLATZER Occluders$45,668
- Resolute$38,116
- Xience V coronary stent system$26,429
- Mitra Clip system$26,258
- WATCHMAN FLX$26,042
- GENERAL VASCULAR ACCESS$24,222
- FFRangio$23,255
- MitraClip System$23,131
- VersaCross Access Solution$20,593
- AMPLATZER AMULET$18,666
How this compares
$2,308,176 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in la Jolla
- Curtiss Stinisla Jolla$759K
- Paul Teirsteinla Jolla$518K
- Richard Schatzla Jolla$119K
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Rahul SharmaStanford$1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
- Christian SpiesBurlingame$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.